Blog

The BISITE Research Group has recently been highlighted by the European Commission as a “key innovator” on its public Innovation Radar platform, thanks to its participation in the European project HERMES. This distinction recognises BISITE’s contribution to the development of technological and biomedical solutions with a real impact on healthcare, specifically in the field of epilepsy.

The HERMES project, which has recently concluded, focused on developing an epileptic activity prediction algorithm capable of anticipating seizures several minutes in advance. This innovation combines regenerative medicine, stem cells and advanced technology, including devices with electrical stimulation chips that allow brain activity to be modulated in a personalised way.

Thanks to this multidisciplinary approach, HERMES has succeeded in bringing together the adaptive capacity of regenerative tissues and cells with technological monitoring and control, creating a system that not only detects epileptic activity but also opens the door to more precise and patient-specific interventions. This combination of biomedicine and advanced technology positions the project as a reference in the development of personalised solutions for epilepsy.

Recognition in Innovation Radar

The inclusion of this innovation in Innovation Radar, the European Commission’s platform that identifies the most relevant advances from EU-funded research projects, highlights the relevance and potential of the algorithm developed. BISITE, as part of the HERMES consortium, has been identified as a “key innovator”, underlining its essential role in the creation and development of this technology.

Innovation Radar also indicates that the innovation has potential to contribute to standardisation, which could facilitate the broader adoption and implementation of similar solutions across the healthcare and technology sectors. This type of recognition not only validates the scientific and technological quality of the work carried out but also positions BISITE as a relevant actor in applied research and European innovation.

A recognition that drives research forward

The recognition of BISITE by Innovation Radar reinforces the group’s position as a reference in applied research in health and technology, and highlights the importance of international collaboration in high-impact projects. HERMES has not only demonstrated technological advances in the prediction of epileptic seizures, but has also served as an example of how European research can combine science, technology and medicine to deliver innovative solutions to real-world challenges.

More information about HERMES: https://hermes-fet.eu